Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v4-FR Version v3-EN
Language French English
Date Updated 2017-10-19 2017-10-19
Drug Identification Number 02358808 02358808
Brand name PRADAXA PRADAXA
Common or Proper name Pradaxa Bottles 60's Pradaxa Bottles 60's
Company Name BOEHRINGER INGELHEIM (CANADA) LTD LTEE BOEHRINGER INGELHEIM (CANADA) LTD LTEE
Ingredients DABIGATRAN ETEXILATE DABIGATRAN ETEXILATE
Strength(s) 150MG 150MG
Dosage form(s) CAPSULE CAPSULE
Route of administration ORAL ORAL
Packaging size Bottle of 60's Bottle of 60's
ATC code B01AE B01AE
ATC description ANTITHROMBOTIC AGENTS ANTITHROMBOTIC AGENTS
Reason for discontinuation Business reasons Business reasons
Anticipated discontinuation date
Actual discontinuation date 2017-10-18 2017-10-18
Remaining supply date 2017-10-18 2017-10-18
Discontinuation status Discontinued Discontinued
Discontinuation decision reversal no no
Tier 3 Status No No
Information on remaining supply
Company comments Pradaxa 150mg 6x10 Blister Pack format remains available Pradaxa 150mg 6x10 Blister Pack format remains available
Health Canada comments